|http://ghr.nlm.nih.gov/ A service of the U.S. National Library of Medicine®|
The official name of this gene is “glycine dehydrogenase (decarboxylating).”
GLDC is the gene's official symbol. The GLDC gene is also known by other names, listed below.
The GLDC gene provides instructions for making an enzyme called glycine dehydrogenase. This enzyme is one of four components (subunits) that make up a large complex called glycine cleavage enzyme. Within cells, this complex is active in specialized energy-producing centers called mitochondria.
As its name suggests, glycine cleavage enzyme processes a molecule called glycine by cutting (cleaving) it into smaller pieces. Glycine is an amino acid, which is a building block of proteins. This molecule also acts as a neurotransmitter, which is a chemical messenger that transmits signals in the brain. The breakdown of excess glycine is necessary for the normal development and function of nerve cells in the brain and spinal cord.
Mutations in the GLDC gene account for about 80 percent of all cases of glycine encephalopathy. More than 40 mutations have been identified in affected individuals. Many of these genetic changes alter single amino acids in glycine dehydrogenase. For example, the most common GLDC mutation in the Finnish population replaces the amino acid serine with the amino acid isoleucine at position 564 in the enzyme (also written as Ser564Ile or S564I). Other mutations insert or delete genetic material in the GLDC gene, or disrupt how genetic information from the gene is spliced together to make a blueprint for producing glycine dehydrogenase.
Some GLDC mutations lead to the production of a nonfunctional version of glycine dehydrogenase, while other mutations reduce but do not eliminate the enzyme's activity. When an altered version of this enzyme is incorporated into the glycine cleavage enzyme complex, it prevents the complex from breaking down glycine properly. As a result, excess glycine can build up to toxic levels in the body's organs and tissues. Damage caused by harmful amounts of this molecule in the brain and spinal cord is responsible for the intellectual disability, seizures, and breathing difficulties characteristic of glycine encephalopathy.
Cytogenetic Location: 9p22
Molecular Location on chromosome 9: base pairs 6,532,463 to 6,645,691
The GLDC gene is located on the short (p) arm of chromosome 9 at position 22.
More precisely, the GLDC gene is located from base pair 6,532,463 to base pair 6,645,691 on chromosome 9.
See How do geneticists indicate the location of a gene? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genelocation) in the Handbook.
You and your healthcare professional may find the following resources about GLDC helpful.
You may also be interested in these resources, which are designed for genetics professionals and researchers.
See How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/naming) in the Handbook.
acids ; amino acid ; breakdown ; dehydrogenase ; disability ; encephalopathy ; enzyme ; gene ; glycine ; isoleucine ; mitochondria ; molecule ; mutation ; population ; protein ; serine ; toxic
You may find definitions for these and many other terms in the Genetics Home Reference Glossary (http://www.ghr.nlm.nih.gov/glossary).
The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.